ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2025
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • 2020-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings
  • Abstract Number: 1301 • ACR Convergence 2022

    Reliable Transition Policy Distribution and Transition Readiness Assessment Questionnaire Completion Using a Digital Intervention in a Pediatric Rheumatology Clinic

    Emily Smitherman1, Livie Huie1, John Bridges2, Randy Cron1, Victoria Gennaro3, Kim Jerkins1, Julie Mauldin1, Linda McAllister4, Annelle Reed3, Daniel Reiff1, Erica Reynolds3, Isabella Sanchez3, Carolyn Smith3, Matthew Stoll1, Tana Webb1, Peter Weiser1, JoAnne Zech1 and Melissa Mannion1, 1University of Alabama at Birmingham, Birmingham, AL, 2University of Alabama at Birmingham/Children's of Alabama, Birmingham, AL, 3Children's of Alabama, Birmingham, AL, 4Children's of Alabama, Trussville, AL

    Background/Purpose: The process of transition from pediatric- to adult-based care should be well-timed, coordinated, and planned to educate and encourage the adolescent towards an adult…
  • Abstract Number: 1299 • ACR Convergence 2022

    Hitting the Target Together: Supporting Shared Decision-Making with Juvenile Idiopathic Arthritis (JIA) Patients Followed in the Out-Patient Rheumatology Setting at the Hospital for Sick Children

    Jo-Anne Marcuz1, Brian Feldman2, Y. Ingrid Goh3, Niina Kim4, Piya Lahiry5, Deborah Levy2, Elizaveta Limenis6, Jeanine McColl7, Christine O'Brien8, Susan Paetkau4, Shirley Tse2, Kristi Whitney8 and Ronald Laxer2, 1Division of Rheumatology and Department of Rehabilitation, The Hospital for Sick Children; University of Toronto, Toronto, ON, Canada, 2Division of Rheumatology, The Hospital for Sick Children; Child Health Evaluative Services, SickKids Research Institute; Department of Paediatrics, University of Toronto, Toronto, ON, Canada, 3Division of Rheumatology, The Hospital for Sick Children; Child Health Evaluative Services, SickKids Research Institute, Toronto, ON, Canada, 4The Hospital for Sick Children, Toronto, ON, Canada, 5Division of Rheumatology, The Hospital for Sick Children; Department of Pediatrics, University of Toronto, Toronto, ON, Canada, 6Division of Rheumatology, The Hospital for Sick Children; Department of Paediatrics, University of Toronto, Toronto, ON, Canada, 7Division of Rheumatology, The Hospital for Sick Children; University of Toronto, Toronto, ON, Canada, 8Division of Rheumatology and Department of Rehabilitation, The Hospital for Sick Children, Toronto, ON, Canada

    Background/Purpose: Juvenile Idiopathic Arthritis (JIA) is the most common chronic rheumatic disease in children with significant morbidity that extends into adulthood. Despite advances in effective…
  • Abstract Number: 1304 • ACR Convergence 2022

    Glucocorticoids Affect Bone Mass and Strength by Inhibiting Osteoprogenitor Cell Maturation

    Thomas Ambrosi1, Mathew Murphy1, Charles KF Chan1 and Nancy Lane2, 1Stanford University, Stanford, CA, 2University of California Davis, Hillsborough, CA

    Background/Purpose: Glucocorticoid (GC) induced osteoporosis remains a significant health issue. While GCs are known to reduce bone formation and bone mass, patients treated with GCs…
  • Abstract Number: 1295 • ACR Convergence 2022

    Targeting Barriers That Prevent Contraception Counseling in an Academic Rheumatology Practice

    Tara Skorupa1, Kristin Sturm2, Aaron Lazorwitz2, Guiset Carvajal Bedoya3, Ju Young Kwag2, JoAnn Zell2 and Kristen Demoruelle2, 1University of Colorado, Aurora, CO, 2University of Colorado Anschutz Medical Campus, Aurora, CO, 3Billings Clinic, Billings, MT

    Background/Purpose: Systemic autoimmune diseases disproportionately affect females of childbearing potential. Many of the medications used to treat systemic autoimmune diseases have suspected or confirmed teratogenic…
  • Abstract Number: 1277 • ACR Convergence 2022

    Improving Patient Appropriate Osteoporosis Screening with Dual Energy X-ray Absorptiometry Scans in an Academic Internal Medicine Practice

    Nithin Pusapati1, Rebecca Fitzpatrick1, Manya Gupta1 and Sonali Khandelwal2, 1Rush University Medical Center, Chicago, IL, 2Rush University, Chicago, IL

    Background/Purpose: Nearly 53.6 million people in America have osteoporosis with increasing incidence each year (Brauer, JAMA 2009). Almost 25% of people with a hip fracture…
  • Abstract Number: 1308 • ACR Convergence 2022

    Prevalence and Therapeutic Practices of Osteoporosis in Sarcoidosis in the United States: A Nationwide Registry Study

    Diala Alawneh1, Moustafa Younis2, Romesa Hassan1, Bashar Alzghoul2, Shiva Arami1, Tricha Shivas3, Mary McGowan3, Khaldoon Alawneh4, Christian Ascoli1 and Nadera Sweiss1, 1University of Illinois at Chicago, Chicago, IL, 2University of Florida, Gainesville, FL, 3Foundation for Sarcoidosis Research, Chicago, IL, 4Jordan University of Science and Technology, Irbid, Jordan

    Background/Purpose: Patients with sarcoidosis are at an increased risk of developing osteoporosis due to the active inflammatory state and chronic corticosteroid use. Proper dosing of…
  • Abstract Number: 1313 • ACR Convergence 2022

    The Role of Tryptophan and Its Metabolites in Risk for Incident Hip Fractures and Frailty: The Cardiovascular Health Study

    Laura Carbone1, Petra Bůžková2, John Robbins3, Howard Fink4, Joshua Barzilay5, Rachel Elam1 and Carlos Isales1, 1Augusta University, Augusta, GA, 2University of Washington, Seattle, WA, 3UC Davis, Davis, CA, 4University of Minnesota, Minneapolis, MN, 5Kaiser Permanente, Atlanta, GA

    Background/Purpose: Essential amino acids including tryptophan (trp) are building blocks for protein, and adequate protein intake is important for skeletal homeostasis. In experimental studies, trp…
  • Abstract Number: 1315 • ACR Convergence 2022

    Building Stronger Bones: Optimizing Osteoporosis Screening at a Primary Care Clinic

    Rebecca Pietro1, Shu Min Lao1 and Geeta Varghese2, 1Mount Sinai Morningside West, New York, NY, 2Ryan Chelsea Clinton Clinic, New York, NY

    Background/Purpose: Osteoporosis is a silent disease characterized by low bone mass and deterioration of bone quality, affecting 25% of women.1 The United States Preventive Services…
  • Abstract Number: 1307 • ACR Convergence 2022

    Effect of Romosozumab in Postmenopausal Women with Knee Osteoarthritis: Results from the FRAME Clinical Trial

    Nancy Lane1, Donald Betah2, Cynthia Deignan2, Mary Oates2, Zhenxun Wang2, Jen Timoshenko3, Aliya Khan4 and Neil Binkley5, 1University of California Davis, Hillsborough, CA, 2Amgen, Inc., Thousand Oaks, CA, 3UCB Pharma, Slough, United Kingdom, 4McMaster University, Oakville, ON, Canada, 5University of Wisconsin, Madison, WI

    Background/Purpose: Osteoarthritis (OA) and osteoporosis (OP) often occur concomitantly in the elderly. The relationship between OA and OP is complex, with increased fracture risk reported…
  • Abstract Number: 1316 • ACR Convergence 2022

    A Cluster of Paget Disease of the Bone in Black or African American Patients in a Veteran Population

    Mariana Urquiaga and Angelo Gaffo, University of Alabama at Birmingham, Birmingham, AL

    Background/Purpose: Genetic and environmental factors have been implicated in the pathogenesis of Paget Disease of the Bone (PDB). Although the disease is described more frequently…
  • Abstract Number: 1297 • ACR Convergence 2022

    A Paediatric-Adult Provider Dyad Care Model Improves Transition from Paediatric to Adult Health Care for Youth with Childhood-Onset Systemic Lupus Erythematosus

    Tala El Tal1, Abdulaziz el Mutairi1, Amanda Steiman2 and Earl Silverman3, 1The Hospital for Sick Children, Division of Rheumatology, Department of Paediatrics, University of Toronto, Toronto, ON, Canada, 2Sinai Health System, Toronto, ON, Canada, 3The Hospital for Sick Children and University of Toronto, Toronto, ON, Canada

    Background/Purpose: Systemic lupus erythematosus (SLE) is a chronic multi-system autoimmune disease affecting 1 in 1000 individuals, of whom 20% develop the disease in childhood. Childhood-onset…
  • Abstract Number: 1321 • ACR Convergence 2022

    Systemic Inflammatory-based Scores and Bone Turnover Ratio as Novel Diagnostic Tools for Chronic Nonbacterial Osteomyelitis (CNO) of the Sternocostoclavicular Region in Adults

    Anne Leerling, Juliette Faber, Natasha Appelman-Dijkstra, Olaf Dekkers and Elizabeth Winter, Leiden University Medical Center, Leiden, Zuid-Holland, Netherlands

    Background/Purpose: Chronic non-bacterial osteomyelitis (CNO) in adults exhibits as sterile osteitis and consequent disrupted bone metabolism favoring bone formation of the sternocostoclavicular region (SCCH). Diagnosis…
  • Abstract Number: 1324 • ACR Convergence 2022

    Treatment Patterns in Women with Post-Menopausal Osteoporosis Using Abaloparatide: A Real-world Observational Study

    Deborah Gold1, Tammy Beckett2, Chad Deal3, Andrew L James4, Jacqueline M Kernaghan5, Mahshid Mohseni6, Abigail McMillan7, Tom Bailey7, Leny Pearman8, John Caminis8, Yamei Wang8 and Setareh A Williams9, 1Duke University Medical Center, Durham, NC, 2Department of Orthopaedics, Orthopaedic Associates of Grand Rapids Research and Education Institute, Grand Rapids, MI, 3Cleveland Clinic, Shaker Heights, OH, 4Columbia Orthopaedic Groups LLP, Columbia, MO, 5Prospect Health Access Network, Springfield, PA, 6Washington University School of Medicine, St. Louis, MO, 7Observational Research Adelphi Real World, Macclesfield, United Kingdom, 8Radius Health, Inc., Waltham, MA, 9CobbsCreek Healthcare, Newtown Square, PA

    Background/Purpose: Abaloparatide (ABL) is approved for treatment of women with postmenopausal osteoporosis (PMO) at high risk for fracture. The study evaluated real-world treatment patterns for…
  • Abstract Number: 1327 • ACR Convergence 2022

    Immune Cell Subsets and Risk of Incident Hip Fracture in Older Adults: The Cardiovascular Health Study

    Rachel Elam1, Petra Buzkova2, Joseph Delaney3, Howard Fink4, Joshua Barzilay5, Laura Carbone1, Rick Saha1, John Robbins6, Kenneth Mukamal7, Rodrigo Valderrabano8, Bruce Psaty2, Russell Tracy9, Nels Olson9, Sally Huber10, Margaret Doyle9, Alan Landay11 and Jane Cauley12, 1Augusta University, Augusta, GA, 2University of Washington, Seattle, WA, 3University of Manitoba, Winnipeg, MB, Canada, 4University of Minnesota, Minneapolis, MN, 5Kaiser Permanente, Atlanta, GA, 6UC Davis, Davis, CA, 7Beth Israel Deaconess Medical Center, Boston, MA, 8Brigham and Women's Hospital, Boston, MA, 9University of Vermont, Burlington, VT, 10University of Vermont, Burlingon, VT, 11Rush University Medical Center, Chicago, IL, 12University of Pittsburgh, PIttsburgh, PA

    Background/Purpose: Cell-mediated immunity may play a role in osteoporosis development. Fracture is the major consequence of osteoporosis. Thus, cell-mediated immunity may impact fracture risk. We…
  • Abstract Number: 1267 • ACR Convergence 2022

    Accuracy of Financial Disclosures in American-Based Rheumatology Journals

    Mary Guan1, Michael Pillinger2 and Aryeh Abeles3, 1New York University Grossman School of Medicine, Brooklyn, NY, 2NYU Grossman School of Medicine, New York, NY, 3New York University Grossman School of Medicine, Wallingford, CT

    Background/Purpose: Prior studies demonstrated that authors of publications may not accurately disclose their financial relationships with industry. One recent study reported that among authors of…
  • « Previous Page
  • 1
  • …
  • 631
  • 632
  • 633
  • 634
  • 635
  • …
  • 2607
  • Next Page »
Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

Embargo Policy

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM CT on October 25. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2026 American College of Rheumatology